Pharmigene, Inc. (7595)
Market Closed
11 Aug, 05:30
TWSE 
NT$
7. 20
0
0%
NT$
- Market Cap
- P/E Ratio
120% Div Yield
2,010 Volume
- Eps
NT$ 7.2
Previous Close Want to track 7595 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Pharmigene, Inc. (7595) Statistics
Valuation metrics
Market Cap -
Enterprise value 961.91M
Trailing P/E (ttm) -6.92
Forward P/E -
PEG ratio -0.21
Price/Sales (ttm) 1.93
Price/Book (mrq) 1.3
Enterprise Value/Revenue 5.12
Enterprise Value/EBITDA -29.31
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 17.33K
Average volume (90 days) 68.52K
Price summary
52-Week low 5.9
52-Week high 14.1
Beta -
50-Day moving average 7.09
200-Day moving average 9.06
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date 1 Dec 2025
Ex-Dividend Date 29 Sep 2025
Last split factor 4:1
Last split Date 29 Sep 2025
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -0.28%
Operating margin -0.24%
Operational effectiveness
Return on assets -0.05%
Return on equity -0.18%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 3.74
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -1.04
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 1.74
Total debt (mrq) -
Total Debt/Equity (mrq) 2.35
Current ratio (mrq) 1.58%
Book value per share (mrq) 5.54
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
